TL;DR
This study identifies two novel subpopulations of lipid-rich macrophages (TREM2+ and MARCO+) that accumulate in larger prostates and are associated with increased urinary symptoms in benign prostatic hyperplasia (BPH). These findings suggest that targeting these specific macrophages could be a new therapeutic strategy for BPH.
What Problem Does This Paper Address?
Benign prostatic hyperplasia (BPH) is a common condition in aging men that causes lower urinary tract symptoms (LUTS). While chronic inflammation is known to be present in BPH tissues, the specific roles of different immune cells, particularly macrophages, and their activation states in the development and progression of BPH have not been well-defined. The authors hypothesize that changes in macrophage phenotypes, specifically those involving lipid metabolism, might contribute to the prostatic hyperplasia seen in BPH. Understanding these macrophage subpopulations could lead to new therapeutic interventions.
Methods
The researchers employed single-cell RNA sequencing (scRNA-seq) to analyze leukocytes from human prostate transition zone tissues. They compared samples from men with small prostates (<40 grams) to those with large prostates (>90 grams). Macrophage subpopulations were identified using specific marker genes. They also used immunofluorescence to determine the localization of these macrophages within the prostate tissue and performed in vitro experiments using cell lines to assess the impact of lipid-loaded macrophages on prostate cell proliferation. Velocity analysis was used to infer the dynamic trajectories of these cell populations.
Datasets
The study utilized scRNA-seq data from 20 human prostate transition zone tissue samples: 10 from patients with small prostates (<40 grams) and 10 from patients with large prostates (>90 grams).
Key Insights and Ideas
- Beyond M1/M2: The study highlights that traditional M1/M2 macrophage polarization classifications are insufficient to capture the complexity of macrophage phenotypes in BPH. Instead, distinct subpopulations with unique functional roles are present.
- Lipid-Rich Macrophages as Key Players: The identification of TREM2+ and MARCO+ macrophages as significantly accumulating in larger prostates and being lipid-rich is a major finding. This suggests a direct link between lipid metabolism in these immune cells and BPH progression.
- Clinical Relevance: The positive correlation between the abundance of these lipid-rich macrophages and patient symptoms (IPSS) and body mass index (BMI) strongly suggests their clinical significance in BPH.
- Proliferation Driver: In vitro data showing that lipid-loaded macrophages can stimulate prostate epithelial and stromal cell proliferation provides a mechanistic link between these macrophages and the hyperplasia characteristic of BPH.
Key Results
- Myeloid cells, particularly macrophages, increase in abundance in larger prostates.
- Two novel macrophage subpopulations, TREM2+ and MARCO+, were identified and found to significantly accumulate in large versus small prostates.
- The abundance of TREM2+ and MARCO+ macrophages positively correlated with patient BMI and urinary symptom scores (IPSS).
- TREM2+ macrophages showed higher intracellular neutral lipid content compared to TREM2- macrophages.
- Lipid-loaded macrophages, when co-cultured with prostate epithelial and stromal cells in vitro, significantly increased their proliferation.
- RNA velocity analysis suggested that TREM2+ and MARCO+ macrophages represent an initial cell state, with their stability increasing as prostate size increases.
Limitations and Future Work
The authors acknowledge that the classification of macrophage subpopulations was primarily empirical due to the lack of fully defined cell states. While the study used THP-1 cells for in vitro experiments, these may not fully represent all macrophage phenotypes in disease states. Future work should focus on investigating the unique biological functions of these identified immune subpopulations and exploring the therapeutic benefits of targeting TREM2+ and MARCO+ macrophages for BPH treatment. Further studies are also needed to determine the specific lipids most relevant to the inflamed BPH microenvironment and to investigate the role of T cell activation in the chronic inflammatory process of BPH.
Summary updated